-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Neutral on QuidelOrtho, Lowers Price Target to $13

Benzinga·05/06/2026 19:26:39
Listen to the news
Citigroup analyst Patrick Donnelly maintains QuidelOrtho (NASDAQ:QDEL) with a Neutral and lowers the price target from $30 to $13.